首页> 中文期刊>国际中医中药杂志 >实脾固肾化瘀方对阿霉素肾纤维化大鼠肾组织I型胶原蛋白、转化生长因子β1、层黏连蛋白及α平滑肌肌动蛋白表达的影响

实脾固肾化瘀方对阿霉素肾纤维化大鼠肾组织I型胶原蛋白、转化生长因子β1、层黏连蛋白及α平滑肌肌动蛋白表达的影响

摘要

Objective To investigate the effects ofShipi-Gushen-Huayu Recipe on the expressions of collagen I, laminin(LN), transforming growth factor-β1(TGF-β1)andα-smooth muscle actin(α-SMA)in adriamycin-induced renal fibrosis in rats.Methods A total of male SD rats were randomly divided into four groups, with 10 rats in each group: a normal group, a model group, a treatment group and a fosinopril sodium group. Except the rats in the normal group, the rest rats were subjected to renal fibrosisvia tail intravenous injection of adriamycin(4 mg/kg). Two weeks after modeling, the rats in the rreatment group and in the fosinopril sodium group were intragastrically administrated daily withShipi-Gushen-Huayu Recipe extract(43 g/kg)and fosinopril solution(2 mg/kg), respectively,both in the normal group and model group with saline. After 30 days, 24-hours urine protein were determined, and the expressions of collagen I, LN, TGF-β1 andα-SMA in kidney tissue were detected with immunohistochemistry staining.Results The expressions of collagen I(24.64±0.67vs. 32.86±0.88), LN(18.71±0.72vs. 28.35±0.87), TGF-β1(14.71±0.68vs. 18.35±0.96)andα-SMA(17.64±0.74vs. 25.86±0.85)in the treatment group were significantly lower than those in the model group(allP<0.01). The expressions of collagen I, LN, TGF-β1 andα-SMA in the fosinopril sodium group were 27.33±0.73, 20.44±0.81, 15.44±0.85 and 19.33±0.77, respectively. There was no statistically significant difference between the expressions of collagen I, LN, TGF-β1 andα-SMA in the treatment group and in the fosinopril sodium group.ConclusionShipi-Gushen-Huayu Recipe can significantly down regulate the expressions of collagen I, LN, TGF-β1 andα-SMA in adriamycin-induced renal fibrosis in rats.%目的:观察实脾固肾化瘀方对阿霉素诱导肾纤维化大鼠I型胶原蛋白、转化生长因子β1(TGF-β1)、层黏连蛋白(LN)及α-平滑肌肌动蛋白(α-SMA)表达的影响。方法40只雄性SD大鼠随机分为正常对照组、模型组、治疗组、福辛普利组,每组10只。除正常对照组外,其余大鼠均采用尾静脉注射阿霉素(4 mg/kg)制作肾纤维化模型。造模后2周,治疗组和福辛普利钠组分别灌胃给予实脾固肾化瘀方浸膏(43 g/kg)和福辛普利钠溶液(2 mg/kg),正常对照组和模型组灌胃给予等体积生理盐水,均为1次/d。给药30 d后,检测尿蛋白,并采用免疫组织化学法检测肾组织I型胶原蛋白、层黏连蛋白(LN)、转化生长因子β1(TGF-β1)及α平滑肌肌动蛋白(α-SMA)表达变化。结果治疗组肾组织 I 型胶原蛋白、LN、TGF-β1及α-SMA 表达[分别为(24.64±0.67)、(18.71±0.72)、(14.71±0.68)、(17.64±0.74)]较模型组[分别为(32.86±0.88)、(28.35±0.87)、(18.35±0.96)、(25.86±0.85)]下降(P<0.01),与福辛普利钠组[分别为(27.33±0.73)、(20.44±0.81)、(15.44±0.85)、(19.33±0.77)]比较差异无统计学意义(P>0.05)。HE染色结果显示,治疗组大鼠肾小球系膜细胞及基底膜增生程度均较模型组明显改善。结论实脾固肾化瘀方可下调阿霉素诱导肾纤维化大鼠I型胶原蛋白、LN、TGF-β1和α-SMA表达。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号